在结直肠癌患者中严重的潜在药物相互作用的风险预测模型:真实世界的数据研究研究
Xiaomei Pei1,2,3, Xiaohu Yang1,2, Lingti Kong1,2,4
1Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Frontiers in pharmacology
|January 28, 2026
概括
潜在的药物相互作用 (pDDI) 对结直肠癌 (CRC) 患者构成风险. 这项研究确定了风险因素,并开发了一种预测模型,以提高CRC患者的安全药物治疗实践.
科学领域:
- 在瘤学瘤学.
- 临床药理学 临床药理学
- 医疗信息学 医疗信息学
背景情况:
- 潜在的药物相互作用 (pDDI) 显著影响结直肠癌 (CRC) 患者的治疗结果.
- 确定pDDI的风险因素对于改善患者预后和确保在临床环境中合理使用药物至关重要.
研究的目的:
- 在住院的CRC患者中确定与pDDI相关的独立风险因素.
- 开发和验证CRC患者pDDI的预测模型,以指导临床实践.
主要方法:
- 一项回顾性队列研究包括2868名住院的CRC患者.
- 使用Medscape进行pDDI评估,并根据确定的独立风险因素构建了一个风险预测模型.
主要成果:
- 超过62%的患者经历了至少一次pDDI,其中50.84%经历了严重的相互作用.
- 独立的风险因素包括药物品种的数量,低albuminemia,和治疗类型.
- 预测模型表现出强的性能,AUC值为0.826 (培训) 和0.824 (验证),通过决策曲线分析显示出良好的校准和临床效用.
结论:
- 在CRC患者中开发了一种经过验证的pDDI预测模型.
- 该模型表现出强大的预测性能和临床适用性,用于识别高风险个体.
- 实施这种模型可以提高药物安全性,并改善临床环境中的患者护理.
相关概念视频
Pharmacokinetics: Drug–Drug Interactions
430
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
430
Drug-Receptor Interactions
7.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.4K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
236
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
236
Factors Affecting Protein-Drug Binding: Drug Interactions
596
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
596
Drug Dosing: Geriatric Patients
232
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
232
Drug Dosing: Obese Patients
254
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
254


